BlueCrest Capital Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

BlueCrest Capital Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-417,000	Closed	-$49.4M	–	740
2021 Q1	$49.4M	Buy	+417,000	New	+$49.3M	0.81%	14
2020 Q4	–	Sell	-45,000	Closed	-$5M	–	475
2020 Q3	$5M	Buy	+45,000	New	+$4.83M	0.18%	116
2016 Q4	–	Sell	-3,333	Closed	-$415K	–	1001
2016 Q3	$415K	Buy	+3,333	New	+$393K	0.01%	563

BlueCrest Capital Management's CBPO Position: Q2 2021 in Review

BlueCrest Capital Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 417,000 shares — an estimated $49.4M sold.

BlueCrest Capital Management first reported a position in CBPO in Q3 2016 and held it in 3 quarters. The position peaked at $49.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

BlueCrest Capital Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
BlueCrest Capital Management sold 417,000 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $49.4M.
BlueCrest Capital Management first reported a position in China Biologic Products Holdings, Inc. in Q3 2016 and held it in 3 quarters.
BlueCrest Capital Management's China Biologic Products Holdings, Inc. position peaked at $49.4M in Q1 2021.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on BlueCrest Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.